Showing results (661-670 of 780) with videos related to
Sort By:
Pageof 78
The Online Journal of Current Clinical Trials|July 1, 1992
Intensive therapy with cisplatin, interleukin-2 and interferon-alpha-2a in patients with metastatic melanoma. A phase II StudyM Sznol, R G Steis, J W Smith, et al.Radiology|August 1, 1991
Three-port perineal sparing techniqueS A Spencer, P N Pareek, I Brezovich, et al.The American Journal of Medicine|June 1, 1983
Therapeutic trial of cryofiltration in patients with rheumatoid arthritisR S Krakauer, A J Wysenbeek, D J Wallace, et al.Toxicology in Vitro : an International Journal Published in Association with BIBRA|June 19, 2015
Multi-walled carbon nanotube induced frustrated phagocytosis, cytotoxicity and pro-inflammatory conditions in macrophages are length dependent and greater than that of asbestosMatthew S P Boyles, Lesley Young, David M Brown, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1990
Toxicity, immunogenicity, and tumor radioimmunodetecting ability of two human monoclonal antibodies in patients with metastatic colorectal carcinomaR G Steis, J A Carrasquillo, R McCabe, et al.Neurology|December 10, 2003
Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes StudyJ R Orland, J Engstrom, J Fridey, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Dose-related immunologic effects of levamisole in patients with cancerJ Janik, W C Kopp, J W Smith, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1990
Treatment of hairy cell leukemia with alternating cycles of pentostatin and recombinant leukocyte A interferon: results of a phase II studyA Martin, S Nerenstone, W J Urba, et al.Journal of the National Cancer Institute|June 17, 1992
Pilot study of interleukin-2 and lymphokine-activated killer cells combined with immunomodulatory doses of chemotherapy and sequenced with interferon alfa-2a in patients with metastatic melanoma and renal cell carcinomaM Sznol, J W Clark, J W Smith, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 22, 2018
High prevalence of non-alcoholic fatty liver disease and metabolic risk factors in Guatemala: A population-based studyA Rivera-Andrade, M F Kroker-Lobos, M Lazo, et al.Pageof 78